A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

Cancer death rates in the UK have hit a record low, but the picture is more complicated than the headline figure suggests.

Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from pancreatic cancer trials presented at ASCO GI Symposium, and ...

Risk-off sentiment dragged the ASX healthcare sector lower this week, headlined by Immutep’s plunge after scrapping a Phase III trial ... Read More The post Scott Power: ASX healthcare sector reels ...

William Shatner has had to undergo surgery following a nasty accident. The incident left fans fearing the worst for the Star Trek icon, who is weeks away from celebrating his 95th birthday. William ...

GPs are often forced to ‘undo incorrect information’ AI provides to patients, the chief medical officer has warned.

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured an advancement in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr ...

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

Bisham Abbey National Sports Centre has announced that it will be funding free prostate-specific antigen (PSA) checks for male employees aged over 40.